GSGG — Destiny Alliance Biotechnology Cashflow Statement
0.000.00%
FinancialsMicro Cap
Annual cashflow statement for Destiny Alliance Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.023 | -0.015 | -0.011 | -0.016 | -0.024 |
| Depreciation | |||||
| Non-Cash Items | — | — | — | — | 0.007 |
| Unusual Items | |||||
| Changes in Working Capital | 0.007 | -0.005 | 0.01 | 0.003 | 0.007 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.016 | -0.02 | -0.001 | -0.013 | -0.009 |
| Financing Cash Flow Items | 0.016 | 0.02 | 0.001 | 0.013 | 0.009 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 0.016 | 0.02 | 0.001 | 0.013 | 0.009 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0 | 0 | 0 | 0 | 0 |